Session information

Tweet

Morning Seminar

[MoS13] Morning Seminar 13　New Treatment (PRRT) for Neuroendocrine Neoplasm

Sat. Feb 19, 2022 7:20 AM - 8:10 AM Room 4 (Room A, 2F, Kyoto International Conference Center)

Chair：Junji Furuse（Department of Medical Oncology, Kyorin University Faculty of Medicine）

Sponsored by FUJIFILM Toyama Chemical Co., Ltd. / Novartis Pharma K.K.

+Add all to schedule

[MoS13-1] How will PRRT change NEN practice? - Focusing on pancreatic neuroendocrine

^○Susumu Hijioka (Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital)

[MoS13-2] Therapeutic Strategies for Neuroendocrine Tumors of the Gastrointestinal Tract

^○Hidekazu Hirano (Department of Gastrointestinal Medical Oncology, National Cancer Center Hospital)

[MoS13-3] Key points for implementing PRRT - Efforts required for radiopharmaceuticals

^○Yasutake Ishikawa (Department of Radiological Technology, National Cancer Center Hospital)